168 related articles for article (PubMed ID: 23116290)
1. Impact of transformation of negative values and regression models on differences between the UK and US EQ-5D time trade-off value sets.
Augestad LA; Rand-Hendriksen K; Kristiansen IS; Stavem K
Pharmacoeconomics; 2012 Dec; 30(12):1203-14. PubMed ID: 23116290
[TBL] [Abstract][Full Text] [Related]
2. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
3. Estimating an EQ-5D-Y-3L Value Set for Indonesia by Mapping the DCE onto TTO Values.
Fitriana TS; Roudijk B; Purba FD; Busschbach JJV; Stolk E
Pharmacoeconomics; 2022 Dec; 40(Suppl 2):157-167. PubMed ID: 36348155
[TBL] [Abstract][Full Text] [Related]
4. Time trade-off and ranking exercises are sensitive to different dimensions of EQ-5D health states.
Rand-Hendriksen K; Augestad LA
Value Health; 2012; 15(5):777-82. PubMed ID: 22867789
[TBL] [Abstract][Full Text] [Related]
5. Crosswalk algorithms for the conversion of mean EQ-5D indices calculated with different value sets.
Nemes S; Garellick G; Salomonsson R; Rolfson O
Scand J Public Health; 2016 Jul; 44(5):455-61. PubMed ID: 27090196
[TBL] [Abstract][Full Text] [Related]
6. The transformation of utilities for health states worse than death: consequences for the estimation of EQ-5D value sets.
Lamers LM
Med Care; 2007 Mar; 45(3):238-44. PubMed ID: 17304081
[TBL] [Abstract][Full Text] [Related]
7. Valuations of EQ-5D health states: are the United States and United Kingdom different?
Johnson JA; Luo N; Shaw JW; Kind P; Coons SJ
Med Care; 2005 Mar; 43(3):221-8. PubMed ID: 15725978
[TBL] [Abstract][Full Text] [Related]
8. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
[TBL] [Abstract][Full Text] [Related]
9. In search of a 'pan-European value set'; application for EQ-5D-3L.
Sajjad A; Versteegh MM; Santi I; Busschbach J; Simon J; Roijen LH
BMC Med Res Methodol; 2023 Jan; 23(1):13. PubMed ID: 36635625
[TBL] [Abstract][Full Text] [Related]
10. Modeling ranking, time trade-off, and visual analog scale values for EQ-5D health states: a review and comparison of methods.
Craig BM; Busschbach JJ; Salomon JA
Med Care; 2009 Jun; 47(6):634-41. PubMed ID: 19433996
[TBL] [Abstract][Full Text] [Related]
11. Chinese time trade-off values for EQ-5D health states.
Liu GG; Wu H; Li M; Gao C; Luo N
Value Health; 2014 Jul; 17(5):597-604. PubMed ID: 25128053
[TBL] [Abstract][Full Text] [Related]
12. A Comparison of Iran and UK EQ-5D-3L Value Sets Based on Visual Analogue Scale.
Kiadaliri AA
Int J Health Policy Manag; 2017 May; 6(5):267-272. PubMed ID: 28812814
[TBL] [Abstract][Full Text] [Related]
13. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states.
Lee YK; Nam HS; Chuang LH; Kim KY; Yang HK; Kwon IS; Kind P; Kweon SS; Kim YT
Value Health; 2009; 12(8):1187-93. PubMed ID: 19659703
[TBL] [Abstract][Full Text] [Related]
14. A Comparison of PROPr and EQ-5D-5L Value Sets.
Pan T; Mulhern B; Viney R; Norman R; Hanmer J; Devlin N
Pharmacoeconomics; 2022 Mar; 40(3):297-307. PubMed ID: 34786591
[TBL] [Abstract][Full Text] [Related]
15. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
[TBL] [Abstract][Full Text] [Related]
16. Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan.
Lee HY; Hung MC; Hu FC; Chang YY; Hsieh CL; Wang JD
J Formos Med Assoc; 2013 Nov; 112(11):699-706. PubMed ID: 24183199
[TBL] [Abstract][Full Text] [Related]
17. Preparatory study for the revaluation of the EQ-5D tariff: methodology report.
Mulhern B; Bansback N; Brazier J; Buckingham K; Cairns J; Devlin N; Dolan P; Hole AR; Kavetsos G; Longworth L; Rowen D; Tsuchiya A
Health Technol Assess; 2014 Feb; 18(12):vii-xxvi, 1-191. PubMed ID: 24568945
[TBL] [Abstract][Full Text] [Related]
18. [Empirical research of measuring elderly health utility in the outskirts of Beijing by using European quality of life 5-dimensions].
Wu YQ; Liu K; Tang X; Cao Y; Wang JW; Li N; Liu JJ; Yu LP; Xu HT; Liu WJ; Wen SS; Hu YH; Li K
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Jun; 44(3):397-402. PubMed ID: 22692310
[TBL] [Abstract][Full Text] [Related]
19. [General population time trade-off values for 42 EQ-5D health states in South Korea].
Jo MW; Lee SI
J Prev Med Public Health; 2007 Mar; 40(2):169-76. PubMed ID: 17426430
[TBL] [Abstract][Full Text] [Related]
20. A comparison of EQ-5D index scores derived from the US and UK population-based scoring functions.
Nan Luo ; Johnson JA; Shaw JW; Coons SJ
Med Decis Making; 2007; 27(3):321-6. PubMed ID: 17545501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
